Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 5/20 | 0.50 |
| ▸ | CA6 | P23280 | 5/20 | 0.50 |
| ▸ | CA7 | P43166 | 5/20 | 0.50 |
| ▸ | CA9 | Q16790 | 5/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | CA4 | P22748 | 4/20 | 0.48 |
| ▸ | CA5A | P35218 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30607521 | 0.98 | CYP2C19 (0.56) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL11871853 | 0.98 | CYP2C19 (0.56) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL10123951 | 0.95 | CYP2C19 (0.58) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL15746957 | 0.91 | CYP2C19 (0.50) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL2182287 | 0.91 | TDP1 (0.56) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL10123924 | 0.91 | CYP2C19 (0.54) | CYP2C19CYP2C9CA12CA6CA7 | |
| Trientine SCHEMBL2186312 | 0.90 | CA12 (0.55) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL24193268 | 0.89 | CYP2C19 (0.52) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL8350386 | 0.89 | CYP2C19 (0.52) | CYP2C19CYP2C9CA12CA6CA7 | |
| SCHEMBL10123895 | 0.89 | CYP2C19 (0.52) | CYP2C19CYP2C9CA12CA6CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160184461-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-06-30 | — | — | US | claimed |
| US-20150165380-A1 | DRAW SOLUTES COMPRISING ALKYL AMMONIUM SALT COMPOUNDS | LOTTE CHEMICAL CORPORATION (KR) | 2015-06-18 | — | — | US | claimed |
| WO-2015005885-A1 | SURFACE PREPARATION METHOD BY ATMOSPHERIC PLASMA SYSTEM FOR BIOMOLECULE IMMOBILIZATION AND OBTAINED SURFACE BY THIS METHOD | DELTAMED YASAM BİLİMLERİ VE PLAZMA TEKNOLOJİLERİ AR-GE SANAYİ VE TİCARET ANONİM SİRKETİ (TR) | 2015-01-15 | — | — | WO | claimed |
| US-8778842-B2 | Sample lysis and coating of reaction surface | QIAGEN GMBH (DE) | 2014-07-15 | — | — | US | claimed |
| US-20140140932-A1 | Functionalized Magnetic Nanoparticles and Use in Imaging Amyloid Deposits and Neurofibrillary Tangles | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-05-22 | — | — | US | claimed |
| EP-2699157-A2 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | The Regents of the University of California (US) | 2014-02-26 | — | — | EP | claimed |
| WO-2012145169-A2 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-10-26 | — | — | WO | claimed |
| US-20110166144-A1 | Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2011-07-07 | — | — | US | claimed |
| EP-1856168-B1 | SAMPLE LYSIS AND COATING OF REACTION SURFACE | QIAGEN GMBH (DE) | 2011-04-27 | — | — | EP | claimed |
| WO-2010014798-A2 | PYRIMIDOTRIAZINEDIONES AND PYRIMIDOPYRIMIDINEDIONES AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-02-04 | — | — | WO | claimed |
| US-20080299557-A1 | Sample Lysis and Coating of Reaction Surface | QIAGEN GMBH (DE) | 2008-12-04 | — | — | US | claimed |
| WO-2007006585-A2 | SYNTHESIS OF A POROUS AND/OR STRATIFIED STRUCTURE MANGANESE OXIDE | ELSPER RUEDIGER (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2003011453-A1 | ADSORBER MATERIALS MADE OF RENEWABLE RAW MATERIALS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2003-02-13 | — | — | WO | claimed |
| US-12583872-B2 | Photosensitizer compounds, methods of manufacture and application to plants | Nutrien Ag Solutions (Canada) Inc. (CA) | 2026-03-24 | — | — | US | disclosed |
| CN-113677685-B | Photosensitizer compound, preparation method and application in plants | 桑科能源股份有限公司 | 2025-03-04 | — | — | CN | disclosed |
| US-20250017866-A1 | POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY | THE JOHNS HOPKINS UNIVERSITY | 2025-01-16 | — | — | US | disclosed |
| US-4051067-A | Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkyleneamines and arylenediamines | MONSANTO COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
| US-4016198-A | Stabilization of unsaturated carboxylic acid esters with mixtures of polyalkylene-amines and arylenediamines | MONSANTO COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
| US-3992251-A | Process of making wet strength paper containing mono primary polyamine and organic dihalide modified, epoxidized polyamide | DIAMOND SHAMROCK CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3979376-A | ANTIBIOTICS | GRUPPO LEPETIT S.P.A. (IT) | 1976-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150165380-A1 | DRAW SOLUTES COMPRISING ALKYL AMMONIUM SALT COMPOUNDS | SLC34A3, SLC43A1, SLC34A1 | CYP2C19 4454/4885CYP2C9 4314/4885CA12 218/4885 |
| US-20140140932-A1 | Functionalized Magnetic Nanoparticles and Use in Imaging Amyloid Deposits and Neurofibrillary Tangles | MAPT, PRNP, APP | CYP2C19 4882/4885CYP2C9 4879/4885CA12 1064/4885 |
| US-20250017866-A1 | POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY | POLRMT, TNNC1, POLI | CYP2C19 4406/4885CYP2C9 4567/4885CA12 3152/4885 |
| US-20160184461-A1 | FUNCTIONALIZED MAGNETIC NANOPARTICLES AND USE IN IMAGING AMYLOID DEPOSITS AND NEUROFIBRILLARY TANGLES | MAPT, PRNP, APP | CYP2C19 4882/4885CYP2C9 4879/4885CA12 1064/4885 |
| US-12583872-B2 | Photosensitizer compounds, methods of manufacture and application to plants | PPOX, CRY1, SOD1 | CYP2C19 2937/4885CYP2C9 2637/4885CA12 278/4885 |
| US-20110166144-A1 | Pyrimidotriazinediones and Pyrimidopyrimidinediones and Methods of Using the Same | DPYD, TYMP, DHFR | CYP2C19 381/4885CYP2C9 834/4885CA12 3644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.